Nursing Intervention of Negative Emotion in Patients with Viral Hepatitis Treated with Interferon

Yue Liu, Feng Min, Jianyun Xu

Abstract


Objective: To evaluate the effect of nursing intervention on negative emotion of patients with viral hepati- tis treated with interferon. Methods: 72 patients with viral hepatitis in our hospital from May 2020 to May 2021 were selected and divided into the control group and the observation group according to the coin method, 36 cases/group, providing routine intervention for the control group and nursing intervention for the observation group. Results: The incidence of adverse reactions (Weight loss rate, leucopenia rate, thrombocytopenia rate and hair loss rate) in the ob- servation group (5.56%) was lower than that in the control group (27.78%), (P < 0.05) with statistical significance. The SAS anxiety score (32.63 ± 3.25) and SDS depression score (31.25 ± 4.23) of the observation group were lower than those of the control group (41.15 ± 4.89) and (40.13 ± 4.89), and the PSQI sleep quality score of the observation group (5.01 ± 0.36) was lower than that of the control group (9.89 ± 1.25), (P<0.05) with statistical significance. The treatment compliance of the observation group (100.00%) was higher than that of the control group (83.33%), (P < 0.05) with statistical significance. Conclusions: The application of nursing intervention in the treatment of viral hepatitis patients with interferon can significantly improve the negative emotions of patients, which is worthy of promotion.

Keywords


Viral hepatitis; Interferon; Negative emotion; Nursing intervention

Full Text:

PDF

References


Li, L.H., Cai, L.Zh., Liu, X.F., et al., 2020. Side effects and inter- vention of interferon in the treatment of chronic viral hepatitis. Chinese Journal of nosocomial infection. 30(12), 1845-1850.

Liu, Y.T., 2020. Effect of entecavir combined with interferon α-2α on HBV-DNA negative conversion in patients with viral hepatitis B. Systems medicine. 5(1), 16-18.

Liu, Z.L., 2020. Effect of entecavir combined with pegylated in- terferon α-2a on HBV-DNA negative and serum YKL-40 and CEA levels in patients with viral hepatitis B. Maternal infant world. (27), 133.

Miao, X.L., 2020. Adverse reactions of pegylated interferon α-2α(pegylated interferon) in the treatment of chronic hepatitis C. Drug evaluation. 17(3), 12-13,15.

Zhang, Ch., Shang, L., 2020. Adefovir dipivoxil combined with recombinant human interferon α2b injection in the treatment of pa- tients with viral hepatitis B. Clinical medical research and practice. 5(5), 46-48.

Guo, Y., 2019. Clinical efficacy and safety of entecavir combined with pegylated interferon α-2a in the treatment of chronic hepatitis B. Northern pharmacy. 16(1), 170-171.

Tang, M.G., Tang, J.Sh., 2020. Tenofovir and entecavir for the treatment of hepatitis B virus positive chronic hepatitis with inef- fective interferon. Heilongjiang medicine. 44(12), 1709-1712.




DOI: https://doi.org/10.12346/jnp.v2i1.6283

Refbacks

  • There are currently no refbacks.


Copyright (c) 2022 Yue Liu, Feng Min, Jianyun Xu

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.